ROLE OF 2% XYLOCAINE GEL IN MANAGING POSTOPERATIVE SORE THROAT IN GENERAL ANESTHESIA PATIENTS
DOI:
https://doi.org/10.62019/540bhe92Keywords:
Postoperative Sore Throat, Xylocaine Gel, General Anesthesia, Endotracheal Intubation, Local AnesthesiaAbstract
Background: Postoperative sore throat (POST) is a common complication following endotracheal intubation, causing significant patient discomfort.
Aim: This study evaluated the efficacy of 2% Xylocaine gel in reducing POST incidence and severity in patients undergoing general anesthesia.
Material and Methods: A prospective observational study was conducted on 84 patients (42 intervention , 42 control) at a tertiary care hospital. The intervention group received topical 2% Xylocaine gel prior to intubation, while the control group received standard care without anesthetic gel. POST incidence, severity (measured on a 10-point VAS), time of onset, and duration were assessed postoperatively. The Xylocaine group demonstrated significantly lower POST incidence (16.7% vs 52.4%, p<0.001) and reduced severity (mean VAS 3.1 vs 6.8, p<0.001). Symptom onset was delayed (3 vs 1 hour, p=0.008) and duration shortened (6 vs 12 hours, p=0.003) in the intervention group. Patient-reported effectiveness was high (mean 8.4/10), with no adverse effects observed.
Conclusion: Topical 2% Xylocaine gel effectively reduces the incidence, severity, and duration of POST, offering a safe and cost-effective strategy to improve postoperative recovery. These findings support its routine use in clinical anesthesia practice.
Downloads
Downloads
Published
Issue
Section
License
All articles published in the Journal of Medical & Health Sciences Review (JMHSR) remain the copyright of their respective authors. JMHSR publishes its content under the Creative Commons Attribution‑NonCommercial 4.0 International License (CC BY‑NC 4.0), which allows readers to freely share, copy, adapt, and build upon the work for non‑commercial purposes, provided proper credit is given to both the authors and the journal.



